CoChat

Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone

Open access
Good, Miranda E., Chiu, Yu-Hsin, Poon, Ivan K.H., Medina, Christopher B., Butcher, Joshua T., Mendu, Suresh K., DeLalio, Leon J., Lohman, Alexander W., Leitinger, Norbert, Barrett, Eugene, Lorenz, Ulrike M., Desai, Bimal N., Jaffe, Iris Z., Bayliss, Douglas A., Isakson, Brant E., Ravichandran, Kodi S. · 2018 · Circulation Research
Cited by 107

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Rationale: Resistant hypertension is a major health concern with unknown cause. Spironolactone is an effective antihypertensive drug, especially for patients with resistant hypertension, and is considered by the World Health Organization as an essential medication. Although spironolactone can act at the mineralocorticoid receptor (MR; NR3C2), there is increasing evidence of MR-independent effects of spironolactone. Objective: Here, we detail the unexpected discovery that Panx1 (pannexin 1) channels could be a relevant in vivo target of spironolactone. Methods and Results: First, we identified spironolactone as a potent inhibitor of Panx1 in an unbiased small molecule screen, which was confirmed by electrophysiological analysis. Next, spironolactone inhibited α-adrenergic vasoconstriction in arterioles from mice and hypertensive humans, an effect dependent on smooth muscle Panx1, but independent of the MR NR3C2. Last, spironolactone acutely lowered blood pressure, which was dependent on smooth muscle cell expression of Panx1 and independent of NR3C2. This effect, however, was restricted to steroidal MR antagonists as a nonsteroidal MR antagonist failed to reduced blood pressure. Conclusions: These data suggest new therapeutic modalities for resistant hypertension based on Panx1 inhibition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circresaha.117.312380

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 107

Metadata

Authors
Good, M. E., Chiu, Y.-H., Poon, I. K. H., Medina, C. B., Butcher, J. T., Mendu, S. K., DeLalio, L. J., Lohman, A. W., Leitinger, N., Barrett, E., Lorenz, U. M., Desai, B. N., Jaffe, I. Z., Bayliss, D. A., Isakson, B. E., & Ravichandran, K. S.
Venue
Circulation Research
Published
2018-02-16
Volume
122
Issue
4
Pages
606-615
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W2773176180
Cited by
107
References
3
FWCI
3.01
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone. https://app.cochat.ai/papers/10.1161/circresaha.117.312380
The paper
Good, M. E., Chiu, Y.-H., Poon, I. K. H., Medina, C. B., Butcher, J. T., Mendu, S. K., DeLalio, L. J., Lohman, A. W., Leitinger, N., Barrett, E., Lorenz, U. M., Desai, B. N., Jaffe, I. Z., Bayliss, D. A., Isakson, B. E., & Ravichandran, K. S. (2018). Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone. Circulation Research. https://doi.org/10.1161/circresaha.117.312380

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.